Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. », Archives of international medicine, pp.1837-1879, 2001. ,
DOI : 10.1001/archinte.161.15.1837
Empiric Antibiotic Therapy and Mortality Among Medicare Pneumonia Inpatients in 10 Western States, Chest, vol.119, issue.5, pp.1420-1426, 1995. ,
DOI : 10.1378/chest.119.5.1420
Impact of Initial Antibiotic Choice on Clinical Outcomes in Community-Acquired Pneumonia, Chest, vol.123, issue.5, pp.1503-1514, 2003. ,
DOI : 10.1378/chest.123.5.1503
Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia, Critical Care Medicine, vol.42, issue.2, pp.42-420, 2014. ,
DOI : 10.1097/CCM.0b013e3182a66b9b
Antibiotics for Bacteremic Pneumonia, Chest, vol.131, issue.2, pp.466-73, 2007. ,
DOI : 10.1378/chest.06-1426
« Canadian guidelines for the initial management of community-?acquired pneumonia: anevidence-?based update by the ,